| 1 |
AENEAS: A Randomized Phase III Trial of Aumolertinib Versus Gefitinib as First-Line Therapy for Locally Advanced or MetastaticNon–Small-Cell Lung Cancer With EGFR Exon 19 Deletion or L858R Mutations
Shun Lü et al. · Journal of Clinical Oncology
Open access |
17 May 2022 |
302 |
| 2 |
Efficacy of Aumolertinib (HS-10296) in Patients With Advanced EGFR T790M+ NSCLC: Updated Post-National Medical Products Administration Approval Results From the APOLLO Registrational Trial
Shun Lü et al. · Journal of Thoracic Oncology
Open access |
19 Nov 2021 |
152 |
| 3 |
MT1‐MMP‐Activated Liposomes to Improve Tumor Blood Perfusion and Drug Delivery for Enhanced Pancreatic Cancer Therapy
Yan Wei, Sha Song, Nianxiu Duan et al. · Advanced Science
Open access |
10 Jul 2020 |
66 |
| 4 |
Development of an UPLC–MS/MS method for simultaneous quantitation of 11 d -amino acids in different regions of rat brain: Application to a study on the associations of d -amino acid concentration changes and Alzheimer’s disease
Zhe Li, Yuping Xing, Xingjie Guo et al. · Journal of Chromatography B
|
11 May 2017 |
44 |
| 5 |
The application of EDTA in drug delivery systems: doxorubicin liposomes loaded via NH4EDTA gradient
Yihui Deng, Yanzhi Song, Zhenjun Huang et al. · International Journal of Nanomedicine
Open access |
Aug 2014 |
39 |
| 6 |
Central nervous system efficacy of aumolertinib versus gefitinib in patients with untreated, EGFR ‐mutated, advanced non‐small cell lung cancer: data from a randomized phase III trial (AENEAS)
Shun Lü et al. · 癌症:英文版
Open access |
17 Jul 2024 |
30 |
| 7 |
Characterization, Large-Scale HSCCC Separation and Neuroprotective Effects of Polyphenols from Moringa oleifera Leaves
Qian Gao, Zongmin Wei, Yun Liu et al. · Molecules
Open access |
20 Jan 2022 |
30 |
| 8 |
A Concise and Efficient Synthesis of Dapagliflozin
Jun Yu, Ying Cao, Haizhou Yu et al. · Organic Process Research & Development
|
27 Jun 2019 |
30 |
| 9 |
Design and synthesis of Lapatinib derivatives containing a branched side chain as HER1/HER2 targeting antitumor drug candidates
Aifeng Lyu, Lei Fang, Shaohua Gou · European Journal of Medicinal Chemistry
Open access |
5 Oct 2014 |
29 |
| 10 |
Enzyme‐Activated Prodrug‐Based Smart Liposomes Specifically Enhance Tumor Hemoperfusion with Efficient Drug Delivery to Pancreatic Cancer Cells and Stellate Cells
Nianxiu Duan, Junjun Li, Sha Song et al. · Advanced Functional Materials
|
11 Aug 2021 |
28 |
| 11 |
Short-term effect of polyethylene glycol loxenatide on weight loss in overweight or obese patients with type 2 diabetes: An open-label, parallel-arm, randomized, metformin-controlled trial
Hongyu Cai, Qianqian Chen, Yale Duan et al. · Frontiers in Endocrinology
Open access |
26 Jan 2023 |
24 |
| 12 |
96-Week Treatment of Tenofovir Amibufenamide and Tenofovir Disoproxil Fumarate in Chronic Hepatitis B Patients
Zhihong Liu et al. · Journal of Clinical and Translational Hepatology
Open access |
Nov 2022 |
24 |
| 13 |
Design, synthesis and evaluation of dual pharmacology β2-adrenoceptor agonists and PDE4 inhibitors
Ling Huang, Wenjun Shan, Qi Zhou et al. · Bioorganic & Medicinal Chemistry Letters
Open access |
21 Nov 2013 |
22 |
| 14 |
381O First-in-human/phase I trial of HS-20089, a B7-H4 ADC, in patients with advanced solid tumors
Jing Wu, Jiawen Zhang, Han Li et al. · Annals of Oncology
Open access |
Oct 2023 |
19 |
| 15 |
Developability profiling of a panel of Fc engineered SARS-CoV-2 neutralizing antibodies
Andrew B. Dippel et al. · mAbs
Open access |
8 Dec 2022 |
19 |
| 16 |
HS-20093, a B7-H3-targeted antibody-drug conjugate in lung cancer: Results from the ARTEMIS-001 phase 1a/b trial
Jianchun Duan et al. · Cancer Cell
Open access |
5 Mar 2026 |
18 |
| 17 |
The endorsement of general and artificial intelligence reporting guidelines in radiological journals: a meta-research study
Jingyu Zhong, Yue Xing, Junjie Anderson Lu et al. · BMC Medical Research Methodology
Open access |
13 Dec 2023 |
18 |
| 18 |
Development and Validation of a Stability-Indicating HPLC Method for Determination of Voriconazole and Its Related Substances
Peng Gu, You Li · Journal of Chromatographic Science
|
Aug 2009 |
18 |
| 19 |
Pegmolesatide for the treatment of anemia in patients undergoing dialysis: a randomized clinical trial
Ping Zhang et al. · EClinicalMedicine
Open access |
28 Oct 2023 |
17 |
| 20 |
Lipocalin 2 (LCN2) confers acquired resistance to almonertinib in NSCLC through LCN2-MMP-9 signaling pathway
Shi Chen, Cong Wang, Zhiwen Fu et al. · Pharmacological Research
Open access |
Feb 2024 |
16 |
| 21 |
Protective Effects and Mechanisms of Polyethylene Glycol Loxenatide Against Hyperglycemia and Liver Injury in db/db diabetic Mice
Yu Zhang, Yufeng Li, Junjun Zhao et al. · Frontiers in Pharmacology
Open access |
6 Dec 2021 |
14 |
| 22 |
Synthesis and pharmacological evaluation of 2,3‐diphenyl acrylonitriles‐bearing halogen as selective anticancer agents
Jiajun Li, Jun Ma, Yabing Xin et al. · Chemical Biology & Drug Design
|
8 Mar 2018 |
14 |
| 23 |
EGFR tyrosine kinase inhibitor HS-10182 increases radiation sensitivity in non-small cell lung cancers with EGFR T790M mutation
Yang Chen, Wang Youyou, Zhao Lujun et al. · Cancer Biology and Medicine
Open access |
2018 |
14 |
| 24 |
Novel anilinopyrimidine derivatives as potential EGFRT790M/C797S Inhibitors: Design, Synthesis, biological activity study
Yanliang Guo, Biao Gao, Peng Gao et al. · Bioorganic & Medicinal Chemistry
Open access |
5 Jul 2022 |
13 |
| 25 |
Antitumor activity of aumolertinib, a third-generation EGFR tyrosine kinase inhibitor, in non-small-cell lung cancer harboring uncommon EGFR mutations
Chen Shi, Cong Zhang, Zhiwen Fu et al. · Acta Pharmaceutica Sinica B
Open access |
10 Mar 2023 |
12 |
| 26 |
In situ PEGylation of recombinant hirudin on an anion exchange chromatography column
Xudong Wang, Xueqin Li, Jun Zhao et al. · Process Biochemistry
|
3 Feb 2017 |
12 |
| 27 |
Nbs1‐mediated DNA damage repair pathway regulates haematopoietic stem cell development and embryonic haematopoiesis
Yu Chen, Jie Sun, Zhenyu Ju et al. · Cell Proliferation
Open access |
14 Feb 2021 |
10 |
| 28 |
Aumolertinib as adjuvant therapy in resected EGFR-mutated non-small-cell lung cancer (ARTS): a double-blind, multicentre, randomised, controlled, phase 3 trial
Liang Zhang, XiQin Zhang, Lin Wu et al. · The Lancet Oncology
|
12 Jan 2026 |
9 |
| 29 |
Polyethylene glycol loxenatide protects diabetic kidneys by inhibiting GRP78/PERK/eIF2α pathway, and improves cardiac injury by suppressing TLR4/NF-κB inflammatory pathway
Chen Shi, Qilin Zhang, Yufeng Li et al. · BMC Cardiovascular Disorders
Open access |
18 Dec 2024 |
9 |
| 30 |
The policies on the use of large language models in radiological journals are lacking: a meta-research study
Jingyu Zhong, Yue Xing, Yangfan Hu et al. · Insights into Imaging
Open access |
Aug 2024 |
9 |
| 31 |
Development of a Modified Process for the Kilogram-Scale Synthesis of c-Met/ALK Inhibitor HS-10168
Jun Yu, Jinjia Wang · Organic Process Research & Development
|
6 Jan 2017 |
9 |
| 32 |
Black-start Scheme for China Southern Power Grid
Zhang Zu · Dianli xitong zidonghua
|
2006 |
9 |
| 33 |
First-line tiragolumab plus atezolizumab and chemotherapy in patients with previously untreated, locally advanced unresectable or metastatic oesophageal cancer (MORPHEUS-EC): a randomised, open-label, phase 1b/2 trial
Jong-Mu Sun, Y. Chao, Sung-Bae Kim et al. · The Lancet Oncology
Open access |
23 Dec 2025 |
8 |
| 34 |
HS-10375, a selective EGFR C797S tyrosine kinase inhibitor, in advanced non–small cell lung cancer
Jianhua Zhan et al. · Journal of Translational Medicine
Open access |
4 Jun 2025 |
8 |
| 35 |
ECM characterization and 3D bioprinted models of NSCLC for investigating stiffness-dependent tumor behavior and drug response
Shiwei Xu, Xin Shun Sun, Yexin Gu et al. · Materials Today Bio
Open access |
May 2025 |
8 |
| 36 |
Overview of preclinical and phase II clinical studies on Pegmolesatide’s long-term erythropoiesis stimulating effect via EPOR-mediated signal transduction
Xiaoying Ma, Zhen Li, Lu Zhang et al. · Journal of Translational Medicine
Open access |
2 Feb 2025 |
8 |
| 37 |
Safety, tolerability, and pharmacokinetics of ibrexafungerp in healthy Chinese subjects: a randomized, double-blind, placebo-controlled phase 1 trial
Xiaoyan Liu, Rui Zhang, Rong Li et al. · Antimicrobial Agents and Chemotherapy
Open access |
16 Nov 2023 |
8 |
| 38 |
Kinetic Optimization and Scale-Up of Site-Specific Thiol-PEGylation of Loxenatide from Laboratory to Pilot Scale
Xudong Wang, Ning-Ning Wei, Shuchang Wang et al. · Industrial & Engineering Chemistry Research
|
15 Oct 2018 |
8 |
| 39 |
Synthesis and characterisation of (Z)-styrylbenzene derivatives as potential selective anticancer agents
Yabing Xin, Jiajun Li, Hongjian Zhang et al. · Journal of Enzyme Inhibition and Medicinal Chemistry
Open access |
2018 |
8 |
| 40 |
Preparation of tenofovir amibufenamide fumarate spherical particles to improve tableting performance and sticking propensity by designing a spherical crystallization process
Yanbo Liu, Xiaolei Wang, Chenyang Zhao et al. · International Journal of Pharmaceutics
|
19 Sep 2024 |
7 |
| 41 |
Clinical efficacy and safety analysis of aumolertinib in real-world treatment of EGFR-mutated advanced non-small-cell lung cancer
Xiaojuan Zhang, Mina Zhang, Xinyang Du et al. · Frontiers in Pharmacology
Open access |
9 Apr 2024 |
7 |
| 42 |
Synthesis of Monofluorocyclohexene via Photocatalytic Defluorinative [4+2] Annulation of gem‐Difluoroalkenes with Unactivated Alkenes
Guangxu Zhang, Dong‐Sheng Li, Fei Xue et al. · Advanced Synthesis & Catalysis
|
Nov 2023 |
7 |
| 43 |
Aumolertinib in NSCLC with leptomeningeal involvement, harbouring concurrent EGFR exon 19 deletion and TP53 comutation: a case report
Zhiquan Qin, Hang Zhang, Peiyuan Yan et al. · Journal of Thoracic Disease
Open access |
Jul 2023 |
7 |
| 44 |
Synthesis of α-allenic aldehydes/ketones from homopropargylic alcohols using a visible-light irradiation system
Dongfang Jiang, Xingxing Zeng, De‐Feng Li et al. · Organic & Biomolecular Chemistry
|
2023 |
7 |
| 45 |
Optimum conditions of ultrasound‐assisted extraction and pharmacological activity study for phenolic compounds of the alga Chondrus ocellatus
Yuexia Zhu, Weiqi Chen, Li Kong et al. · Journal of Food Processing and Preservation
|
21 Jan 2022 |
7 |
| 46 |
Improvement of the key flavour compounds of fermented garlic by fermentation process optimization
Leng Yun-wei, Huang Shuangshuang, Bing Chen · AFRICAN JOURNAL OF BIOTECHNOLOGY
Open access |
31 Oct 2020 |
7 |
| 47 |
Novel 7-formyl-naphthyridyl-ureas derivatives as potential selective FGFR4 inhibitors: Design, synthesis, and biological activity studies
Changan Sun, Lei Fang, Xiaobing Zhang et al. · Bioorganic & Medicinal Chemistry
Open access |
10 Apr 2019 |
7 |
| 48 |
Stereoselective N-glycosylation with N4-acyl cytosines and efficient synthesis of gemcitabine
Tongchao Liu, Jiadeng Tang, Jianpeng Liang et al. · Tetrahedron
|
17 Jan 2019 |
7 |
| 49 |
A chiral high-performance liquid chromatography–tandem mass spectrometry method for the stereospecific determination of morinidazole in human plasma
Kan Zhong, Zhiwei Gao, Qin Li et al. · Journal of Chromatography B
|
2 May 2014 |
7 |
| 50 |
Stimulation of nitric oxide production contributes to the antiplatelet and antithrombotic effect of new peptide pENW (pGlu-Asn-Trp)
Yamin Liu, Wenjing Luo, Huan Yang et al. · Thrombosis Research
|
21 May 2015 |
7 |